Spruce Biosciences, Inc.
Spruce Biosciences reported 2025 financial results, with $48.9M in cash and cash equivalents, and announced Dale Hooks as Chief Commercial Officer. The company is on track for a BLA submission in Q4 2026 for TA-ERT and secured $50M in growth capital.
Spruce Biosciences, Inc. SPRB is headquartered in South San Francisco, CA.
Posted Mar 9, 2026, 11:33 AM UTC
10